机构:[1]The First Affiliated Hospital of Kunming Medical University, Kunming, China; rm3816205@163.com.昆明医科大学附属第一医院生殖遗传科[2]The First Affiliated Hospital of Kunming Medical University, Kunming, China; 1446845851@qq.com.昆明医科大学附属第一医院[3]The First Affiliated Hospital of Kunming Medical University, Kunming, China; greenca@126.com.昆明医科大学附属第一医院[4]Thr first affiliated hospital of Kunming medical Univresity, Kunming, China; xiaopaosha@163.com.[5]The First affiliated hospital of Kunming Medical University, Kunming, China; wanruixue0104@163.com.昆明医科大学附属第一医院[6]The first affiliated Hospital of Kunming Medical University, Kunming, China; 839321525@qq.com.昆明医科大学附属第一医院[7]the First Affiliated Hospital of Kunming Medical University, Kunming, China; 154638914@qq.com.昆明医科大学附属第一医院[8]The first affiliated Hospital of Kunming Medical University, Kunming, China; 2404968836@qq.com.昆明医科大学附属第一医院[9]The First Affiliated Hospital of Kunming Medical University, Kunming, China; kunhuawang1@163.com.昆明医科大学附属第一医院[10]The first affiliated hospital of Kunming medical university, Department of reproduction and genetics, No. 295 Xichang Rd, Kunming, China, 650032; tanglikm@163.com.外科科室医技科室生殖遗传科昆明医科大学附属第一医院[11]The first affiliated hospital of Kunming medical university, No. 295 Xchang Rd., Kunming, China, 650032; kmshh1982@126.com.昆明医科大学附属第一医院
Maternal subclinical hypothyroidism (SCH) is a risk factor for adverse pregnancy outcomes. However, it is still unclear whether SCH affects male fertility. The aim of this study was to determine the association between paternal SCH and clinical outcomes after in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI).
This retrospective study included 2511 couples with paternal euthyroidism (n=2282) or SCH (n=229) who visited our clinic for infertility treatment between April 1, 2017 and September 30, 2019. The primary outcomes were the fertilization rate and clinical pregnancy rate; the secondary outcomes were the good-quality embryo rate, blastocyst formation rate, implantation rate and early miscarriage rate. These outcomes were compared between the euthyroidism and the SCH groups after adjusting for various potential confounders.
The mean paternal ages in the euthyroidism and SCH groups were 34.5 and 36.0 years, respectively (p = 0.002). Semen parameters and sperm DNA fragmentation index were similar between the two groups (all p > 0.05). The adjusted fertilization (0.69 vs. 0.71, p = 0.30), good-quality embryo (0.49 vs. 0.52, p = 0.31), blastocyst formation (0.51 vs. 0.53, p = 0.57) and early miscarriage (0.11 vs. 0.10, p = 0.81) rates were also similar between the two groups. We did, however, identify a significantly decreased adjusted clinical pregnancy rate (95% CI) and implantation rate (95% CI) in the paternal SCH group compared to the euthyroidism group [0.32 (0.26-0.40) vs. 0.42 (0.40-0.45), p = 0.009 for the clinical pregnancy rate; 0.24 (0.19-0.29) vs. 0.29 (0.27-0.31), p = 0.037 for the implantation rate]. A subsequent stratified analysis indicated that these differences were only significant in men aged ≥35 years (p = 0.009 and 0.022, respectively) and not in men <35 years (p = 0.39 and 0.45, respectively).
Paternal SCH was associated with worse clinical outcomes after IVF/ICSI, whereas this detrimental impact was only present in males ≥35 years old. Prospective-designed studies and molecular-based basic research are warranted to confirm these results and to clarify the mechanisms underlying these associations.
第一作者机构:[1]The First Affiliated Hospital of Kunming Medical University, Kunming, China; rm3816205@163.com.
通讯作者:
通讯机构:[9]The First Affiliated Hospital of Kunming Medical University, Kunming, China; kunhuawang1@163.com.[10]The first affiliated hospital of Kunming medical university, Department of reproduction and genetics, No. 295 Xichang Rd, Kunming, China, 650032; tanglikm@163.com.[11]The first affiliated hospital of Kunming medical university, No. 295 Xchang Rd., Kunming, China, 650032; kmshh1982@126.com.
推荐引用方式(GB/T 7714):
Rao Meng,Yang Zexing,Su Cunmei,et al.Paternal subclinical hypothyroidism affects the clinical outcomes of in vitro fertilization/intracytoplasmic sperm injection.[J].THYROID.2021,31(1):12-22.doi:10.1089/thy.2020.0154.
APA:
Rao Meng,Yang Zexing,Su Cunmei,Zhao Zihan,Wan Ruixue...&Zhao Shuhua.(2021).Paternal subclinical hypothyroidism affects the clinical outcomes of in vitro fertilization/intracytoplasmic sperm injection..THYROID,31,(1)
MLA:
Rao Meng,et al."Paternal subclinical hypothyroidism affects the clinical outcomes of in vitro fertilization/intracytoplasmic sperm injection.".THYROID 31..1(2021):12-22